Application 022472

Type
BLA
Sponsor
MANNKIND

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
022472Afrezzainsulin human351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AFREZZAINSULIN RECOMBINANT HUMANPOWDER;INHALATION4 UNITS/INHNoNo
002AFREZZAINSULIN RECOMBINANT HUMANPOWDER;INHALATION8 UNITS/INHNoNo
003AFREZZAINSULIN RECOMBINANT HUMANPOWDER;INHALATION12 UNITS/INHNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AFREZZAINSULIN HUMANMannkind Corporation29f4637b-e204-425b-b89c-7238008d8c102026-05-30Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA022472
ndc (product): 47918-880
ndc (product): 47918-878
ndc (product): 47918-891
ndc (product): 47918-902
ndc (product): 47918-874
ndc (product): 47918-898

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 32 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47918-874AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-874AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-874AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-874AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-874AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-878AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-878AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-878AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-878AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-878AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-880AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-880AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-880AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-880AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-880AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-882AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-891AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-891AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-891AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-891AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-891AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-894AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-898AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-898AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-898AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-898AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-898AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-902AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-902AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-902AfrezzaInsulin HumanMannkind CorporationNDACurrent
47918-902AfrezzaInsulin HumanMannkind CorporationBLACurrent
47918-902AfrezzaInsulin HumanMannkind CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84845SUPPL 2026-01-28
84844SUPPL 2026-01-28
84837SUPPL 2026-01-26
84836SUPPL 2026-01-26
73386SUPPL 2023-02-06
73381SUPPL 2023-02-06
56144SUPPL2020-03-23
56111SUPPL2020-03-23
53810SUPPL2020-03-23
49923SUPPL2020-03-23
49905SUPPL2020-03-23
49904SUPPL2020-03-23
44759ORIG2020-03-23
44505ORIG2020-03-23
38748SUPPL2020-03-23
38747ORIG2020-03-23
29765SUPPL2020-03-23
29764ORIG2020-03-23
22030ORIG2020-03-23
17627SUPPL2020-03-23
17626SUPPL2020-03-23
17625SUPPL2020-03-23
17624SUPPL2020-03-23
17623SUPPL2020-03-23
17622SUPPL2020-03-23
7440SUPPL2020-03-23
7439SUPPL2020-03-23
7438SUPPL2020-03-23
66368APPL2020-03-22